Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History $1.18 +0.03 (+2.61%) Closing price 07/3/2025 03:33 PM EasternExtended Trading$1.16 -0.01 (-1.27%) As of 07/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemomab Therapeutics Stock Price Performance The Chemomab Therapeutics (CMMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 19.81%, with a year-to-date return of -34.81%. In the past month, the stock has decreased 10.61%, reflecting recent market activity. As of the latest close, Chemomab Therapeutics traded at $1.18 with a market cap of $22.26 million and volume of 39,709 shares. Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.72%1 Month Performance-10.61%3 Month Performance+12.38%Year-To-Date Performance-34.81%1 Year Performance+19.81% CMMB Stock Chart for Saturday, July, 5, 2025 CMMB Chart by TradingView Chemomab Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$1.18$1.18$1.19$1.1639,709 shs$22.25 million07/03/2025$1.15$1.18+2.61%$1.19$1.1639,709 shs$22.26 million07/02/2025$1.16$1.15-0.86%$1.21$1.15139,184 shs$21.69 million07/01/2025$1.16$1.16$1.22$1.15110,619 shs$21.88 million06/30/2025$1.17$1.16-0.85%$1.20$1.1688,658 shs$21.88 million06/27/2025$1.19$1.17-1.98%$1.22$1.1769,875 shs$22.07 million06/26/2025$1.20$1.19-0.53%$1.23$1.1933,678 shs$22.51 million06/25/2025$1.20$1.20$1.23$1.20114,904 shs$22.63 million06/24/2025$1.18$1.20+1.69%$1.24$1.1786,693 shs$22.63 million06/23/2025$1.20$1.18-1.67%$1.23$1.1881,503 shs$22.26 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$1.22$1.20-1.64%$1.25$1.1994,544 shs$22.63 million06/19/2025$1.22$1.22$1.25$1.101.81 million shs$23.01 million06/18/2025$1.20$1.22+1.67%$1.25$1.101.81 million shs$23.01 million06/17/2025$1.23$1.20-2.44%$1.23$1.1934,112 shs$22.63 million06/16/2025$1.20$1.23+2.50%$1.26$1.1976,498 shs$23.19 million06/13/2025$1.22$1.20-1.64%$1.24$1.1970,658 shs$22.63 million06/12/2025$1.20$1.22+1.44%$1.25$1.2038,265 shs$23.01 million06/11/2025$1.30$1.20-7.48%$1.29$1.20412,629 shs$22.68 million06/10/2025$1.32$1.30-1.52%$1.35$1.26103,915 shs$24.51 million06/09/2025$1.32$1.32-0.12%$1.34$1.24146,892 shs$24.92 million06/06/2025$1.32$1.32+0.12%$1.37$1.3076,717 shs$24.92 million06/05/2025$1.35$1.32-1.92%$1.35$1.2978,110 shs$24.89 million06/04/2025$1.34$1.35+0.43%$1.38$1.3379,159 shs$19.32 million Related Companies MIST Stock Chart ENTX Stock Chart ADAG Stock Chart IVVD Stock Chart SKYE Stock Chart VNRX Stock Chart ORMP Stock Chart CHRS Stock Chart IOBT Stock Chart SRZN Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMMB Stock Alerts